🇺🇸 FDA
Patent

US 7479483

Tumor-targeted drug delivery systems and uses thereof

granted A61KA61K31/00A61K31/704

Quick answer

US patent 7479483 (Tumor-targeted drug delivery systems and uses thereof) held by FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR
Grant date
Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/00, A61K31/704, A61K38/08, A61K38/10